Global medical device regulators are updating oversight protocols for artificial intelligence and machine learning software (SaMD). The updated frameworks place strict post-market monitoring obligations on software vendors to mitigate algorithmic drift in clinical settings.
Real-World Performance Validation
Under the new mandates, developers must submit quarterly performance evaluations comparing algorithmic diagnostics against panel radiologist reviews. Software updating beyond original training distributions will require expedited re-certification prior to clinical deployment.
Liability and Deployment Bottlenecks
Healthcare providers report that increased compliance requirements are extending integration timelines for automated triage tools. However, hospital risk committees view the rigid validation guidelines as a necessary prerequisite to mitigating institutional liability.